Digestive Diseases and Sciences

, Volume 59, Issue 9, pp 2264–2271 | Cite as

Whites and Blacks Have Similar Risk of Metachronous Advanced Colorectal Neoplasia

  • Joann Kwah
  • Paul C. SchroyIII
  • Brian C. Jacobson
  • Audrey H. Calderwood
Original Article



Current guidelines for surveillance of colonic neoplasia are based on data from predominantly white populations, yet whether these recommendations are applicable to blacks is unknown.


To define the prevalence of advanced colorectal neoplasia (ACN) among whites and blacks undergoing surveillance colonoscopy.


This was a retrospective, cross-sectional analysis of asymptomatic, average-risk non-Hispanic white (N = 246) and non-Hispanic black (N = 203) patients with colorectal neoplasia who underwent baseline screening colonoscopy between January 1, 2000, and December 31, 2007, and a surveillance colonoscopy before December 31, 2010, at an academic safety-net hospital. The main outcome measure was the prevalence of ACN, defined as a tubular adenoma or sessile serrated adenoma (SSA) ≥10 mm, any adenoma with villous histology or high-grade dysplasia, any serrated lesion with dysplasia, or invasive cancer at surveillance.


During a median follow-up of 4.3 years, the overall prevalence of ACN at surveillance was similar among blacks and whites (11.3 vs. 9.8 %; P = 0.59) with an odds ratio of 1.18 (95 % CI 0.65–2.26). Blacks and whites with non-advanced neoplasia had similar rates of ACN at the 1–3, 4–5, and >5 year follow-up intervals. Blacks with ACN or multiplicity at baseline had higher rates of ACN at the 1- to 3-year interval compared with whites, but the difference was non-significant (26.7 vs. 12.5 %; P = 0.32). No interval cancers were observed for either group.


The overall prevalence of ACN was similar between non-Hispanic blacks and non-Hispanic whites undergoing surveillance in a safety-net healthcare setting suggesting that current surveillance guidelines are appropriate for both blacks and whites.


Colorectal neoplasia Post-polypectomy surveillance Race Colonoscopy 



This work was supported by a grant from NIH NIDDK K08-DK090150-02 (Calderwood). The study sponsor had no role in the design, analysis, or interpretation of results.

Conflict of interests



  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2013;62:10–29.CrossRefGoogle Scholar
  2. 2.
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–560.PubMedCrossRefGoogle Scholar
  3. 3.
    Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRefGoogle Scholar
  4. 4.
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160.PubMedCrossRefGoogle Scholar
  5. 5.
    Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2009;116:544–573.CrossRefGoogle Scholar
  6. 6.
    Doubeni CA, Laiyemo AO, Klabunde CN, Young AC, Field TS, Fletcher RH. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med. 2010;38:184–191.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Shavers VL. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc. 2007;99:733–748.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Use of colorectal cancer tests–United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 2008;57:253–258.Google Scholar
  9. 9.
    Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:1623–1630.PubMedCrossRefGoogle Scholar
  10. 10.
    Weber TK, Chin HM, Rodriguez-Bigas M, et al. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA. 1999;281:2316–2320.PubMedCrossRefGoogle Scholar
  11. 11.
    Ashktorab H, Smoot DT, Carethers JM, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003;9:1112–1117.PubMedGoogle Scholar
  12. 12.
    Corley DA, Jensen CD, Marks AR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172–180.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Penn E, Garrow D, Romagnuolo J. Influence of race and sex on prevalence and recurrence of colon polyps. Arch Intern Med. 2010;170:1127–1132.PubMedCrossRefGoogle Scholar
  14. 14.
    Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–841.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Laiyemo AO, Doubeni C, Brim H, et al. Short- and long-term risk of colorectal adenoma recurrence among whites and blacks. Gastrointest Endosc. 2013;77:447–454.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Office of Management and Budget (OMB). Revisions to the standards for the classification of federal data on race and ethnicity. Federal Regist. 1997;62:58781–58790.Google Scholar
  17. 17.
    Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.PubMedCrossRefGoogle Scholar
  18. 18.
    Schroy PC 3rd, Coe A, Chen CA, O’Brien MJ, Heeren TC. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med. 2013;159:13–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol. 1982;35:830–841.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–168.PubMedCrossRefGoogle Scholar
  21. 21.
    Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371–379.PubMedGoogle Scholar
  23. 23.
    Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328:901–906.PubMedCrossRefGoogle Scholar
  24. 24.
    US Census Data Profile of General Population and Housing Characteristics: Boston, MA 2010. Accessed on 3/4/2014.
  25. 25.
    Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077–1085.PubMedCrossRefGoogle Scholar
  26. 26.
    Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc. 2000;51:433–437.PubMedCrossRefGoogle Scholar
  27. 27.
    Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–333.PubMedCrossRefGoogle Scholar
  28. 28.
    Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology. 2001;120:1077–1083.PubMedCrossRefGoogle Scholar
  29. 29.
    Siddiqui AA, Patel A, Huerta S. Determinants of compliance with colonoscopy in patients with adenomatous colon polyps in a veteran population. Aliment Pharmaco Ther. 2006;24:1623–1630.CrossRefGoogle Scholar
  30. 30.
    Ayanian JZ, Sequist TD, Zaslavsky AM, et al. Physician reminders to promote surveillance colonoscopy for colorectal adnomas. J Gen Intern Med. 2008;23:762–767.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Joann Kwah
    • 2
  • Paul C. SchroyIII
    • 3
  • Brian C. Jacobson
    • 3
  • Audrey H. Calderwood
    • 1
  1. 1.Section of GastroenterologyBoston Medical CenterBostonUSA
  2. 2.Division of GastroenterologyMontefiore Medical CenterBronxUSA
  3. 3.Section of GastroenterologyBoston Medical CenterBostonUSA

Personalised recommendations